Platelet P2Y12 Receptor Inhibition and Perioperative Patient Management
P2Y12 receptor inhibitor use increases bleeding risk in surgical patients by inhibiting platelet aggregation. Preoperative monitoring, platelet transfusion, and targeted reversal strategies with novel therapies may help to optimize patient management.
Authors
- Kenichi A. Tanaka (ORCID: https://orcid.org/0000-0002-5051-1365)
- Jerrold H. Levy (ORCID: https://orcid.org/0000-0003-3766-4962)
- Michael A. Mazzeffi (ORCID: https://orcid.org/0000-0003-2955-4915)
- Udaya Tantry
- Paul A. Gurbel
Institutions
- Duke University (US)
- Oklahoma City University (US)
- Sinai Hospital (US)
- University of Oklahoma Medical Center (US)
- University of Oklahoma Health Sciences Center (US)
- University of Virginia (US)
- University of Oklahoma (US)
Publication Details
- Journal
- Anesthesiology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1097/aln.0000000000005148
- Citations
- 2
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.80